Literature DB >> 23279898

Modeling the global transmission of antiviral-resistant influenza viruses.

Dennis L Chao1.   

Abstract

BACKGROUND: The mutations that confer resistance to antiviral agents are thought to be detrimental, or at best neutral, to influenza virus fitness. The fact that resistant influenza strains can circulate and sometimes replace sensitive strains is of great public health concern.
OBJECTIVES: We used mathematical modeling to test various hypotheses about the transmission of antiviral-resistant influenza viruses by comparing the model's output with the observed rise in antiviral resistance of seasonal A(H1N1) influenza viruses between 2006 and 2009.
METHODS: We developed a mathematical model of the transmission of influenza among 321 cities around the globe. In the model, influenza strains resistant to antiviral agents competed with sensitive strains. RESULTS AND
CONCLUSIONS: We found that a resistant strain of influenza could not displace the sensitive strain as rapidly as has been observed unless it was more transmissible than the sensitive strain in the general population. We believe that an antiviral-resistant strain displaced the antiviral-sensitive seasonal A(H1N1) virus by hitchhiking on an escape mutation. Because of the complex global patterns of influenza circulation, tracking the emergence and spread of antiviral resistance must be a coordinated global effort.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23279898      PMCID: PMC3747505          DOI: 10.1111/irv.12043

Source DB:  PubMed          Journal:  Influenza Other Respir Viruses        ISSN: 1750-2640            Impact factor:   4.380


  36 in total

1.  A reverse genetics study of resistance to neuraminidase inhibitors in an influenza A/H1N1 virus.

Authors:  Yacine Abed; Nathalie Goyette; Guy Boivin
Journal:  Antivir Ther       Date:  2004-08

2.  The global circulation of seasonal influenza A (H3N2) viruses.

Authors:  Colin A Russell; Terry C Jones; Ian G Barr; Nancy J Cox; Rebecca J Garten; Vicky Gregory; Ian D Gust; Alan W Hampson; Alan J Hay; Aeron C Hurt; Jan C de Jong; Anne Kelso; Alexander I Klimov; Tsutomu Kageyama; Naomi Komadina; Alan S Lapedes; Yi P Lin; Ana Mosterin; Masatsugu Obuchi; Takato Odagiri; Albert D M E Osterhaus; Guus F Rimmelzwaan; Michael W Shaw; Eugene Skepner; Klaus Stohr; Masato Tashiro; Ron A M Fouchier; Derek J Smith
Journal:  Science       Date:  2008-04-18       Impact factor: 47.728

3.  The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

Authors:  J A L Ives; J A Carr; D B Mendel; C Y Tai; R Lambkin; L Kelly; J S Oxford; F G Hayden; N A Roberts
Journal:  Antiviral Res       Date:  2002-08       Impact factor: 5.970

4.  Oseltamivir-resistant influenza A viruses are transmitted efficiently among guinea pigs by direct contact but not by aerosol.

Authors:  Nicole M Bouvier; Anice C Lowen; Peter Palese
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

5.  The genomic and epidemiological dynamics of human influenza A virus.

Authors:  Andrew Rambaut; Oliver G Pybus; Martha I Nelson; Cecile Viboud; Jeffery K Taubenberger; Edward C Holmes
Journal:  Nature       Date:  2008-04-16       Impact factor: 49.962

6.  The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance.

Authors:  Lone Simonsen; Cécile Viboud; Bryan T Grenfell; Jonathan Dushoff; Lance Jennings; Marita Smit; Catherine Macken; Mami Hata; Julia Gog; Mark A Miller; Edward C Holmes
Journal:  Mol Biol Evol       Date:  2007-05-23       Impact factor: 16.240

7.  Mapping the antigenic and genetic evolution of influenza virus.

Authors:  Derek J Smith; Alan S Lapedes; Jan C de Jong; Theo M Bestebroer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Science       Date:  2004-06-24       Impact factor: 47.728

8.  Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo.

Authors:  J Carr; J Ives; L Kelly; R Lambkin; J Oxford; D Mendel; L Tai; N Roberts
Journal:  Antiviral Res       Date:  2002-05       Impact factor: 5.970

9.  Phylogenetic analysis reveals the global migration of seasonal influenza A viruses.

Authors:  Martha I Nelson; Lone Simonsen; Cecile Viboud; Mark A Miller; Edward C Holmes
Journal:  PLoS Pathog       Date:  2007-09-14       Impact factor: 6.823

10.  Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir.

Authors:  Marie-Anne Rameix-Welti; Vincent Enouf; Frédérique Cuvelier; Patricia Jeannin; Sylvie van der Werf
Journal:  PLoS Pathog       Date:  2008-07-25       Impact factor: 6.823

View more
  5 in total

1.  Ancestral and Compensatory Mutations that Promote Antiviral Resistance in Influenza N1 Neuraminidase Revealed by a Phylonumerics Approach.

Authors:  Elma H Akand; Kevin M Downard
Journal:  J Mol Evol       Date:  2018-10-09       Impact factor: 2.395

2.  Assessing the use of antiviral treatment to control influenza.

Authors:  S C Kramer; S Bansal
Journal:  Epidemiol Infect       Date:  2014-10-02       Impact factor: 4.434

3.  Coupling high-throughput genetics with phylogenetic information reveals an epistatic interaction on the influenza A virus M segment.

Authors:  Nicholas C Wu; Yushen Du; Shuai Le; Arthur P Young; Tian-Hao Zhang; Yuanyuan Wang; Jian Zhou; Janice M Yoshizawa; Ling Dong; Xinmin Li; Ting-Ting Wu; Ren Sun
Journal:  BMC Genomics       Date:  2016-01-12       Impact factor: 3.969

4.  Population-level mathematical modeling of antimicrobial resistance: a systematic review.

Authors:  Anna Maria Niewiadomska; Bamini Jayabalasingham; Jessica C Seidman; Lander Willem; Bryan Grenfell; David Spiro; Cecile Viboud
Journal:  BMC Med       Date:  2019-04-24       Impact factor: 8.775

5.  Combination effects of peramivir and favipiravir against oseltamivir-resistant 2009 pandemic influenza A(H1N1) infection in mice.

Authors:  Sehee Park; Jin Il Kim; Ilseob Lee; Sangmoo Lee; Min-Woong Hwang; Joon-Yong Bae; Jun Heo; Donghwan Kim; Seok-Il Jang; Hyejin Kim; Hee Jin Cheong; Jin-Won Song; Ki-Joon Song; Luck Ju Baek; Man-Seong Park
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.